The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Collegium Pharmaceutical Inc shares valued at $351,320 were sold by Smith Thomas B on Sep 13 ’24. At $36.62 per share, Smith Thomas B sold 9,593 shares. The insider’s holdings dropped to 53,816 shares worth approximately $1.62 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Smith Thomas B purchased 373 shares, netting a total of over 13,794 in proceeds.
Before that, Smith Thomas B had added 9,220 shares to its account. In a trade valued at $337,516, the Officer bought Collegium Pharmaceutical Inc shares for $36.61 each.
As published in a research note from H.C. Wainwright on July 30, 2024, Collegium Pharmaceutical Inc [COLL] has been rated up from a Neutral to a Buy and the price target has been revised to $47. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early June. As of May 10, 2024, Piper Sandler has decreased its “an Overweight” rating to a “Neutral” for COLL. Earlier on May 10, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for COLL stock which previously was a “a Buy”.
Analyzing COLL Stock Performance
During the last five days, there has been a drop of approximately -12.52%. Over the course of the year, Collegium Pharmaceutical Inc shares have dropped approximately -1.95%. Shares of the company reached a 52-week high of $42.29 on 10/07/24 and a 52-week low of $29.69 on 11/13/24. A 50-day SMA is recorded $36.66, while a 200-day SMA reached $35.50. Nevertheless, trading volume fell to 0.73 million shares from 0.72 million shares the previous day.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 29.35, which, if violated, would cause prices to drop to 28.51. In the upper region, resistance lies at 31.36. The next price resistance is at 32.53. RSI (Relative Strength Index) is 28.26 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.22, which suggests the price will decrease in the coming days. Percent R is at 92.17%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
